# OnCo record shr-a1921 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/shr-a1921/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "shr-a1921" ;
  schema:name "SHR-A1921"@en ;
  schema:description "SHR-A1921 is an experimental drug that delivers chemotherapy to TROP2-bearing cells. Early solid-tumor findings are distinct from the later trials testing its comparative benefit."@en ;
  schema:url <https://onco.cc/drugs/shr-a1921/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.ccell.2025.09.012>, <https://pubmed.ncbi.nlm.nih.gov/41135519/>, <https://clinicaltrials.gov/study/NCT05154604> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:targets <https://onco.cc/targets/trop2/> ;
  onco:companies <https://onco.cc/companies/hengrui/> ;
  onco:trials <https://onco.cc/trials/nct06394492/>, <https://onco.cc/trials/nct06474455/>, <https://onco.cc/trials/nct05765032/> .